Author:
du Plessis Nicolette M.,Haeri Mazanderani Ahmad,Motaze Nkengafac Villyen,Ngobese Makhosazane,Avenant Theunis
Abstract
AbstractHepatitis A virus (HAV) infection is one of the most important global causes of viral hepatitis. Recent reviews suggested that HAV endemicity in South Africa could shift from high to intermediate. A hospital-based HAV seroprevalence study was conducted between February 2018 and December 2019 in Pretoria, South Africa. Systematic sampling was performed on children and adolescents (1–15 years) who attended outpatient services. Participants with a known HIV status and valid HAV serology results were included. Of the 1220 participants, the median age was 7 years (IQR: 4–11), with 648 (53.11%) males and 572 (46.89%) females. Of 628 (51.48%) HIV-infected participants, most (329, 71.83%) were both immunologically and virologically controlled or had low-level viremia (74, 16.16%). Almost three-quarters (894, 73.28%) were living in formal dwellings, and just over half (688, 56.39%) had access to clean water sources inside the house. Increasing age was associated with testing HAV IgG-positive (OR 1.25; 95% CI 1.20–1.30, p < 0.001), with 19.8% of participants one year of age compared with 86.7% of participants 15 years of age. This study suggests that South Africa has an intermediate HAV seroprevalence, with rates < 90% by 10 years of age (68.6%). Increased age and informal dwellings are statistically associated with HAV seropositivity, while HIV status does not significantly influence HAV seropositivity.
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Franco, E., Meleleo, C., Serino, L., Sorbara, D. & Zaratti, L. Hepatitis A: Epidemiology and prevention in developing countries. World 4, 68–73 (2012).
2. WHO. WHO position paper on hepatitis A vaccines–June 2012. Wkly. Epidemiol. Rec. 87, 261–276 (2012).
3. Jacobsen, K. H. & Koopman, J. S. Declining hepatitis A seroprevalence: A global review and analysis. Epidemiol. Infect. 132, 1005–1022 (2004).
4. Jacobsen, K. H. & Wiersma, S. T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 28, 6653–6657 (2010).
5. Haeri Mazanderani, A., Motaze, N. V., McCarthy, K., Suchard, M. & Du Plessis, N. M. Hepatitis A virus seroprevalence in South Africa-Estimates using routine laboratory data, 2005–2015. PLoS ONE 14, e0216033 (2019).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献